New post-hoc analyses extend understanding of the efficacy and safety of lurasidone in the treatment of schizophrenia
31 March 2015 | By Victoria White
Takeda and Sunovion today announced the results from 3 post-hoc analyses evaluating the efficacy and safety of lurasidone in patients with schizophrenia...